39 Somatic NF1 alterations as potential biomarker for response to immune checkpoint inhibition in recurrent ovarian cancer
Objectives: There remains no standardized prognostic biomarker for response to immune checkpoint inhibitor (ICI) therapy in recurrent ovarian cancer. Methods: This retrospective cohort study reviewed patients with ovarian, fallopian, peritoneal cancer of any histology who received ICI at a large ref...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |